NCT04730258
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04730258
Title A Study of CFI-400945 With or Without Azacitidine or Decitabine in Patients With AML, MDS or CMML (TWT-202)
Acronym TWT-202
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Treadwell Therapeutics, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
Norton Cancer Institute - Saint Matthews Louisville Kentucky 40207 United States Details
New York Presbyterian Weill Cornell Medical Center New York New York 10021 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
The University of Texas MD Anderson Cancer Centre Houston Texas 77030 United States Details
University of Alberta Edmonton Alberta T6G2B7 Canada Details
Princess Margaret Cancer Center Toronto Ontario M5G2C1 Canada Details
Queen Mary Hospital Hong Kong Hong Kong Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field